NYSE - Delayed Quote USD

Envista Holdings Corporation (NVST)

18.53 -0.60 (-3.14%)
At close: May 17 at 4:00 PM EDT
18.89 +0.36 (+1.94%)
After hours: May 17 at 7:22 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,562,900.00
2,566,500.00
2,569,100.00
2,508,900.00
1,929,100.00
Cost of Revenue
1,128,800.00
1,126,000.00
1,094,300.00
1,082,400.00
874,300.00
Gross Profit
1,434,100.00
1,440,500.00
1,474,800.00
1,426,500.00
1,054,800.00
Operating Expense
1,168,300.00
1,150,700.00
1,155,600.00
1,120,300.00
1,011,300.00
Operating Income
265,800.00
289,800.00
319,200.00
306,200.00
43,500.00
Net Non Operating Interest Income Expense
-59,600.00
-63,400.00
-38,400.00
-54,100.00
-62,500.00
Other Income Expense
-281,500.00
-281,300.00
3,100.00
2,400.00
-1,000.00
Pretax Income
-75,300.00
-54,900.00
283,900.00
254,500.00
-20,000.00
Tax Provision
45,100.00
45,300.00
45,900.00
-9,000.00
-62,500.00
Net Income Common Stockholders
-120,400.00
-100,200.00
243,100.00
340,500.00
33,300.00
Diluted NI Available to Com Stockholders
-120,400.00
-100,200.00
243,100.00
340,500.00
33,300.00
Basic EPS
-0.73
-0.60
1.49
2.11
0.21
Diluted EPS
-0.73
-0.60
1.37
1.92
0.20
Basic Average Shares
168,975.00
166,900.00
162,900.00
161,200.00
159,600.00
Diluted Average Shares
168,975.00
166,900.00
177,600.00
177,600.00
164,100.00
Total Operating Income as Reported
7,500.00
31,500.00
319,200.00
306,200.00
43,500.00
Total Expenses
2,297,100.00
2,276,700.00
2,249,900.00
2,202,700.00
1,885,600.00
Net Income from Continuing & Discontinued Operation
-120,400.00
-100,200.00
243,100.00
340,500.00
33,300.00
Normalized Income
34,580.00
103,857.00
238,000.00
263,500.00
42,500.00
Interest Expense
59,600.00
63,400.00
38,400.00
54,100.00
62,500.00
Net Interest Income
-59,600.00
-63,400.00
-38,400.00
-54,100.00
-62,500.00
EBIT
-15,700.00
8,500.00
322,300.00
308,600.00
42,500.00
EBITDA
143,400.00
171,100.00
484,400.00
460,500.00
205,600.00
Reconciled Cost of Revenue
1,128,800.00
1,126,000.00
1,094,300.00
1,082,400.00
874,300.00
Reconciled Depreciation
159,100.00
162,600.00
162,100.00
151,900.00
163,100.00
Net Income from Continuing Operation Net Minority Interest
-120,400.00
-100,200.00
238,000.00
263,500.00
42,500.00
Total Unusual Items Excluding Goodwill
-258,300.00
-258,300.00
--
--
--
Total Unusual Items
-258,300.00
-258,300.00
--
--
--
Normalized EBITDA
401,700.00
429,400.00
484,400.00
460,500.00
205,600.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-103,320.00
-54,243.00
--
--
--
12/31/2020 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
 
ICUI ICU Medical, Inc.
103.99
-2.15%
 
STMN.SW Straumann Holding AG
121.45
-1.70%
 
BLCO Bausch + Lomb Corporation
14.65
-3.87%
 
CLPBY Coloplast A/S
12.56
+1.62%
 
KRMD KORU Medical Systems, Inc.
2.2800
-3.39%
 
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
 
ATRC AtriCure, Inc.
23.14
+2.25%
 
STVN Stevanato Group S.p.A.
20.71
-0.96%
 
UTMD Utah Medical Products, Inc.
69.72
-1.04%